Clinical Trial Update: Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing oxytocin to placebo in Prader-Willi syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Prader Willi Syndrome | Phase 2 | Status: COMPLETED